Effect of Betanin, the Major Pigment of Red Beetroot (<i>Beta vulgaris</i> L.), on the Activity of Recombinant Human Cytochrome P450 Enzymes

Most of the currently available drugs are derived from natural sources, but they are used only after extensive chemical modifications to improve their safety and efficacy. Natural products are used in health supplements and cosmetic preparations and have been used as auxiliary drugs or alternative m...

Full description

Bibliographic Details
Main Authors: Sung Ho Lim, Seoungpyo Bae, Ho Seon Lee, Hyo-Kyung Han, Chang-Ik Choi
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/16/9/1224
_version_ 1797578091315331072
author Sung Ho Lim
Seoungpyo Bae
Ho Seon Lee
Hyo-Kyung Han
Chang-Ik Choi
author_facet Sung Ho Lim
Seoungpyo Bae
Ho Seon Lee
Hyo-Kyung Han
Chang-Ik Choi
author_sort Sung Ho Lim
collection DOAJ
description Most of the currently available drugs are derived from natural sources, but they are used only after extensive chemical modifications to improve their safety and efficacy. Natural products are used in health supplements and cosmetic preparations and have been used as auxiliary drugs or alternative medicines. When used in combination with conventional drugs, these herbal products are known to alter their pharmacokinetics and pharmacodynamics, reducing their therapeutic effects. Moreover, herb–drug interactions (HDIs) may have serious side effects, which is one of the major concerns in health practice. It is postulated that HDIs affect the pathways regulating cytochrome P450 enzymes (CYPs). Betanin, the chief pigment of red beetroot (<i>Beta vulgaris</i> L.), has various types of pharmacological activity, such as anti-inflammatory, antioxidant, and anticancer effects. However, the potential risk of HDIs for betanin has not yet been studied. Thus, we aimed to predict more specific HDIs by evaluating the effects of betanin on CYPs (CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, and CYP3A4), the major phase I metabolic enzymes, using fluorescence-/luminescence-based assays. Our results showed that betanin inhibited CYP3A4 activity in a dose-dependent manner (IC<sub>50</sub> = 20.97 µΜ). Moreover, betanin acted as a competitive inhibitor of CYP3A4, as confirmed by evaluating Lineweaver–Burk plots (<i>Ki</i> value = 19.48 µΜ). However, no significant inhibitory effects were observed on other CYPs. Furthermore, betanin had no significant effect on CYP1A2, CYP2B6, or CYP2C9 induction in HepG2 cells. In conclusion, betanin acted as a competitive inhibitor of CYP3A4, and thus it should be used cautiously with other drugs that require metabolic enzymes as substrates. Additional in vivo studies and clinical trials are needed to further elucidate the HDIs of betanin.
first_indexed 2024-03-10T22:17:02Z
format Article
id doaj.art-4baf1b0e26664ed69a2a8327c9eee7a1
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T22:17:02Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-4baf1b0e26664ed69a2a8327c9eee7a12023-11-19T12:24:17ZengMDPI AGPharmaceuticals1424-82472023-08-01169122410.3390/ph16091224Effect of Betanin, the Major Pigment of Red Beetroot (<i>Beta vulgaris</i> L.), on the Activity of Recombinant Human Cytochrome P450 EnzymesSung Ho Lim0Seoungpyo Bae1Ho Seon Lee2Hyo-Kyung Han3Chang-Ik Choi4Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang 10326, Republic of KoreaIntegrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang 10326, Republic of KoreaIntegrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang 10326, Republic of KoreaBK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang 10326, Republic of KoreaIntegrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang 10326, Republic of KoreaMost of the currently available drugs are derived from natural sources, but they are used only after extensive chemical modifications to improve their safety and efficacy. Natural products are used in health supplements and cosmetic preparations and have been used as auxiliary drugs or alternative medicines. When used in combination with conventional drugs, these herbal products are known to alter their pharmacokinetics and pharmacodynamics, reducing their therapeutic effects. Moreover, herb–drug interactions (HDIs) may have serious side effects, which is one of the major concerns in health practice. It is postulated that HDIs affect the pathways regulating cytochrome P450 enzymes (CYPs). Betanin, the chief pigment of red beetroot (<i>Beta vulgaris</i> L.), has various types of pharmacological activity, such as anti-inflammatory, antioxidant, and anticancer effects. However, the potential risk of HDIs for betanin has not yet been studied. Thus, we aimed to predict more specific HDIs by evaluating the effects of betanin on CYPs (CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, and CYP3A4), the major phase I metabolic enzymes, using fluorescence-/luminescence-based assays. Our results showed that betanin inhibited CYP3A4 activity in a dose-dependent manner (IC<sub>50</sub> = 20.97 µΜ). Moreover, betanin acted as a competitive inhibitor of CYP3A4, as confirmed by evaluating Lineweaver–Burk plots (<i>Ki</i> value = 19.48 µΜ). However, no significant inhibitory effects were observed on other CYPs. Furthermore, betanin had no significant effect on CYP1A2, CYP2B6, or CYP2C9 induction in HepG2 cells. In conclusion, betanin acted as a competitive inhibitor of CYP3A4, and thus it should be used cautiously with other drugs that require metabolic enzymes as substrates. Additional in vivo studies and clinical trials are needed to further elucidate the HDIs of betanin.https://www.mdpi.com/1424-8247/16/9/1224<i>Beta vulgaris</i> L.betanincytochrome P450 enzymesfluorescence-based assayHepG2 cellsherb–drug interactions
spellingShingle Sung Ho Lim
Seoungpyo Bae
Ho Seon Lee
Hyo-Kyung Han
Chang-Ik Choi
Effect of Betanin, the Major Pigment of Red Beetroot (<i>Beta vulgaris</i> L.), on the Activity of Recombinant Human Cytochrome P450 Enzymes
Pharmaceuticals
<i>Beta vulgaris</i> L.
betanin
cytochrome P450 enzymes
fluorescence-based assay
HepG2 cells
herb–drug interactions
title Effect of Betanin, the Major Pigment of Red Beetroot (<i>Beta vulgaris</i> L.), on the Activity of Recombinant Human Cytochrome P450 Enzymes
title_full Effect of Betanin, the Major Pigment of Red Beetroot (<i>Beta vulgaris</i> L.), on the Activity of Recombinant Human Cytochrome P450 Enzymes
title_fullStr Effect of Betanin, the Major Pigment of Red Beetroot (<i>Beta vulgaris</i> L.), on the Activity of Recombinant Human Cytochrome P450 Enzymes
title_full_unstemmed Effect of Betanin, the Major Pigment of Red Beetroot (<i>Beta vulgaris</i> L.), on the Activity of Recombinant Human Cytochrome P450 Enzymes
title_short Effect of Betanin, the Major Pigment of Red Beetroot (<i>Beta vulgaris</i> L.), on the Activity of Recombinant Human Cytochrome P450 Enzymes
title_sort effect of betanin the major pigment of red beetroot i beta vulgaris i l on the activity of recombinant human cytochrome p450 enzymes
topic <i>Beta vulgaris</i> L.
betanin
cytochrome P450 enzymes
fluorescence-based assay
HepG2 cells
herb–drug interactions
url https://www.mdpi.com/1424-8247/16/9/1224
work_keys_str_mv AT sungholim effectofbetaninthemajorpigmentofredbeetrootibetavulgarisilontheactivityofrecombinanthumancytochromep450enzymes
AT seoungpyobae effectofbetaninthemajorpigmentofredbeetrootibetavulgarisilontheactivityofrecombinanthumancytochromep450enzymes
AT hoseonlee effectofbetaninthemajorpigmentofredbeetrootibetavulgarisilontheactivityofrecombinanthumancytochromep450enzymes
AT hyokyunghan effectofbetaninthemajorpigmentofredbeetrootibetavulgarisilontheactivityofrecombinanthumancytochromep450enzymes
AT changikchoi effectofbetaninthemajorpigmentofredbeetrootibetavulgarisilontheactivityofrecombinanthumancytochromep450enzymes